Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine
Reference57 articles.
1. Sawyer DB. Anthracyclines and heart failure. N Engl J Med. 2013;368(12):1154–6.
2. Torres VM, Simic VD. Doxorubicin-induced oxidative injury of cardiomyocytes—do we have right strategies for prevention. Cardiotoxic Oncol Treat. 2012:1–43.
3. Salvatorelli E, Menna P, Chello M, Covino E, Minotti G. Modeling human myocardium exposure to doxorubicin defines the risk of heart failure from low-dose doxorubicin. J Pharmacol Exp Ther. 2017;362(2):263–70.
4. Jean SR, Tulumello DV, Riganti C, Liyanage SU, Schimmer AD, Kelley SO. Mitochondrial targeting of doxorubicin eliminates nuclear effects associated with cardiotoxicity. ACS Chem Biol. 2015;10(9):2007–15.
5. Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SVN, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Investig. 2014;124(2):617–30.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献